Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lusti-Narasimhan

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
BJOG : an International Journal of Obstetrics and Gynaecology|October 23, 2014
Lessons learnt from sexual and reproductive health and HIV linkages for multipurpose prevention technology service deliveryM Lusti-Narasimhan, L Collins, J Hopkins
BJOG : an International Journal of Obstetrics and Gynaecology|October 23, 2014
Making the case for multipurpose prevention technologies: the socio-epidemiological rationaleH Boonstra, S Barot, M Lusti-Narasimhan
BJOG : an International Journal of Obstetrics and Gynaecology|January 8, 2014
Multipurpose prevention technologies: maximising positive synergiesM Lusti-Narasimhan, M Merialdi, B Holt
BJOG : an International Journal of Obstetrics and Gynaecology|October 23, 2014
Advancing the sexual and reproductive health and human rights of women beyond 2015M Lusti-Narasimhan, R Khosla, M Temmerman, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|October 23, 2014
Ensuring successful development and introduction of multipurpose prevention technologies through an innovative partnership approachB Young Holt, J Romano, J Manning, et al.
Cytotechnology|February 24, 2012
Downstream processing of insect cell culturesA R Bernard, M Lusti-Narasimhan, K M Radford, et al.
The Journal of Biological Chemistry|February 9, 1996
A molecular switch of chemokine receptor selectivity. Chemical modification of the interleukin-8 Leu25 --> Cys mutantM Lusti-Narasimhan, A Chollet, C A Power, et al.
Annals of the New York Academy of Sciences|October 31, 1996
The molecular basis of selectivity between CC and CXC chemokines: the possibility of chemokine antagonists as anti-inflammatory agentsT N Wells, M Lusti-Narasimhan, C W Chung, et al.
The Journal of Biological Chemistry|February 10, 1995
Mutation of Leu25 and Val27 introduces CC chemokine activity into interleukin-8M Lusti-Narasimhan, C A Power, B Allet, et al.
Journal of Leukocyte Biology|January 1, 1996
Selectivity and antagonism of chemokine receptorsT N Wells, C A Power, M Lusti-Narasimhan, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
BJOG : an International Journal of Obstetrics and Gynaecology|October 23, 2014
Lessons learnt from sexual and reproductive health and HIV linkages for multipurpose prevention technology service deliveryM Lusti-Narasimhan, L Collins, J Hopkins
BJOG : an International Journal of Obstetrics and Gynaecology|October 23, 2014
Making the case for multipurpose prevention technologies: the socio-epidemiological rationaleH Boonstra, S Barot, M Lusti-Narasimhan
BJOG : an International Journal of Obstetrics and Gynaecology|January 8, 2014
Multipurpose prevention technologies: maximising positive synergiesM Lusti-Narasimhan, M Merialdi, B Holt
BJOG : an International Journal of Obstetrics and Gynaecology|October 23, 2014
Advancing the sexual and reproductive health and human rights of women beyond 2015M Lusti-Narasimhan, R Khosla, M Temmerman, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|October 23, 2014
Ensuring successful development and introduction of multipurpose prevention technologies through an innovative partnership approachB Young Holt, J Romano, J Manning, et al.
Cytotechnology|February 24, 2012
Downstream processing of insect cell culturesA R Bernard, M Lusti-Narasimhan, K M Radford, et al.
The Journal of Biological Chemistry|February 9, 1996
A molecular switch of chemokine receptor selectivity. Chemical modification of the interleukin-8 Leu25 --> Cys mutantM Lusti-Narasimhan, A Chollet, C A Power, et al.
Annals of the New York Academy of Sciences|October 31, 1996
The molecular basis of selectivity between CC and CXC chemokines: the possibility of chemokine antagonists as anti-inflammatory agentsT N Wells, M Lusti-Narasimhan, C W Chung, et al.
The Journal of Biological Chemistry|February 10, 1995
Mutation of Leu25 and Val27 introduces CC chemokine activity into interleukin-8M Lusti-Narasimhan, C A Power, B Allet, et al.
Journal of Leukocyte Biology|January 1, 1996
Selectivity and antagonism of chemokine receptorsT N Wells, C A Power, M Lusti-Narasimhan, et al.
Pageof 1